High-risk Medications in Elderly Patients in Our Hospital Based on List of High-risk Perioperative Medications

doi:10.19803/j.1672-8629.2020.10.09

Abstract

Abstract: Objective To evaluate high-risk medications in elderly patients in our hospital based on the list of high-risk perioperative medications in order to provide more evidence for rational medications in perioperative elderly patients. Methods A total of 230 elderly patients during the perioperative period were selected from January 2018 to December 2018. The list of high-risk perioperative medications for the elderly released in 2019 was used as the criteria to evaluate the high-risk medications detected. Results In the 230 patients, 279 medications were detected, 36.52% (84/230) of whom received high-risk medications during the perioperative period, and 29.13% (67/230) used two or more types of high-risk drugs. A total of 37 types of drugs were detected, among which dexmedetomidine, diazepam and NSAID were more frequently used, accounting for 20.43%, 14.35% and 11.30% respectively. A total of 3 patients developed adverse reactions after perioperative administration. Conclusion There are potential drug risks to perioperative elderly patients in our hospital, so we should strengthen the regulation of perioperative medications in elderly patients and improve the quality of medications.

Key words: perioperative period, list of high-risk medications, elderly surgical petients

CLC Number:

R969.3

DONG Na, HE Dan, WU Xiaoyan, ZHANG Haixia. High-risk Medications in Elderly Patients in Our Hospital Based on List of High-risk Perioperative Medications[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 692-696.

References

[1] Sun XL, Hu X.Current situation and rational use of clinical drugs in the elderl[J]. Chin J Clin Healthe(中国临床保健杂志), 2018, 21(1): 123-126.
[2] Jian ZJ, Wang Y.Evaluation and intervention of polypharmacy in the elderly[J]. Chin J Geriatr(中华老年医学杂志), 2019, 38(10): 1097-1100.
[3] Liang YJ, Ma XC.Comprehensive perioperative assessment and treatment of high-risk elderly patients[J]. Chin J Geriatrics Res (Electronic Edition)(中华老年病研究电子杂志), 2019, 6(1): 12-16.
[4] By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults[J]. Journal of the American Geriatrics Society, 2019, 67(4): 674-694.
[5] Gallagher PF, O'connor MN, O'mahony D.Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/STAR criteria[J]. Clin Pharmacol Ther, 2011, 89(6): 845-854.
[6] Mohanty S, Rosenthal RA, Russell MM, et al.Optimal Perioperative Management of the Geriatric Patient: A Best Practices Guideline from the American College of Surgeons NSQIP and the American Geriatrics Society[J]. Journal of the American College of Surgeons, 2016, 222(5): 930-947.
[7] Castanheira L, Fresco P, Macedo AF.Guidelines for the management of chronic medication in the perioperative period: systematic review and formal consensus[J]. J Clin Pharm Ther, 2011, 36: 446-467.
[8] Wang K, Shen JH, Jiang DC, et al.Development of a list of high-risk perioperative medications for the elderly: a Delphi method[J]. Expert Opinion on Drug Safety, 2019, 18(9): 853-859.
[9] Feng YJ, Hung GL.Comparison of rationality of prophylactic antibacterials in perioperative patients in hospital[J]. Anti Infect Pharm(抗感染药学), 2019, 16(6): 958-961.
[10] Endocrinology and Metabolism Branch of Chinese Association of Geriatric Research, Committee of Clinical Toxicology of Chinese Society of Toxicology. Expert Consensus on Risk Management of Polypharmacy in Elderly[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(10): 627-640.
[11] Shen Q, Liu Ch, Wang YQ.Analysis of 400 Serious ADR Reports in the Elderly[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2013, 10(4): 228-231.
[12] Liang HY, Zhang L, Xing XX, et al.Analysis on prevalence and influencing factors of potentially inappropriate medication in elderly patients in outpatient and emergency departments in china[J]. ADRJ(药物不良反应杂志), 2017, 19(1): 22-30.
[13] Barends CR, Absalom A, van Minnen B, et al. Dexmedetomidine versus Midazolam in Procedural Sedation. A Systematic Review of Efficacy and Safety[J]. PloS one, 2017, 12(1): e0169525.
[14] Shi YC.The effect of intraoperative infusion of dexmedetomidine on stress response and quality of recovery in the elderly[D]. Fudan University, 2014.
[15] Lu L, Wang SB, Rao WW, et al.Sleep Duration and Patterns in Chinese Older Adults: A Comprehensive Meta-analysis[J]. International Journal of Biological Sciences, 2017, 13(6): 682-689.
[16] Liu X, Pan Q, Xu XK, et al.Research on potentially inappropriate medication use in elderly patients:based on the clinical use of Criteria of potentially inappropriate medications for older adults in China(2017)[J]. Journal of Pharmaceutical Practice(药学实践杂志), 2019, 37(3): 283-288.
[17] Chou R, Gordon DB, de Leon-casasola OA, et al.Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council[J]. J Pain, 2016, 17(2): 131-157.
[18] Wang RR, Rao YF, Yu ZW, et al.Appropriate Use of Non- steroidal Anti-inflammatory Drugs during the Perioperative Period: A Retrospective Multicenter Study[J]. Chin Pharm(中国药学杂志), 2019, 54(13): 1104-1108.
[19] Zang CP, Shen HZ.Non-steroidal Anti-inflammatory Drugs: Adverse Reactions and Prevention Measures[J]. World Latest Medicine Information (Electronic Version)(世界最新医学信息文摘), 2018, 18(95): 25-26,36.